TBPN Podcast Summary
Episode: $1B GLP-1 Lessons, New AI Careers, China’s 2030 Master Plan
Hosts: John Coogan & Jordi Hays
Guests:
- Sam Broner (Better Money)
- Jonathan Slotkin (Geisinger, Scrub Capital)
- Liz Hoffman (Semaphore/Compound Interest)
- Bret Taylor (Sierra)
- Ariyan Kabir (GrayMatter Robotics)
- Atif Siddiqi (Branch)
Date: April 6, 2026
Theme: Exploring rapid scale in AI-enabled businesses, regulation and disruption in telehealth, China’s evolving tech ambitions, the capital reshaping of the AI economy, and the real-world impact on industry, labor, and national security.
Episode Overview
This episode dives into several "frontier" forces shaping business and technology: the new wave of lightning-scaling startups (exemplified by the GLP-1 telehealth saga), the transformation of AI into both a capital sink and career engine, the changing global tech dynamic with a focus on China’s 2030 strategy, and practical real-world applications from stablecoin clearance to robotics and modern workforce finance.
The hosts and guests offer critical perspectives on:
- The reality behind 1-person, $1B startups and the distinction between true, sustainable innovation and viral hype.
- The regulatory pitfalls plaguing telehealth and supplement businesses.
- Exploding costs and new organizational structures in AI companies.
- China's state-driven technological gambit for global dominance by 2030.
- How new startups are leveraging both regulatory changes and artificial intelligence to upend traditional industries.
Key Discussion Points
1. The "$1B, One-Person" GLP-1 Telehealth Story
[02:16–19:49 | John Coogan, Jordi Hays]
- The Hype: New York Times story claims MedV, a two-person startup, is on track for $1.8B in revenue via GLP-1 (weight loss) drug prescriptions — dubbed a "$1B company."
- The Reality Check: Hosts dissect the numbers and reveal:
- Margin questions due to heavy outsourcing (doctors, pharmacies, compliance).
- The real value might be much less as revenue ≠ market cap—especially with potential litigation and regulatory risk.
- Aggressive, possibly illegal, marketing tactics: 800+ fake doctor ads running on Facebook.
- FDA warning letters for misbranding, class action for spamming, and looming litigation.
- Quote [07:37 | John]: “You quickly wind up an estimate of pretty thin margins...it’s totally possible to get to a valuation that's lower than a billion dollars, depending on how everything flows through.”
- Comparison with Previous Health Startups: Relates to the Juul/Puff Bar saga—massive revenues wiped out by regulatory baggage.
- Ethics Discussion: The line between “disruption” and outright deception in telehealth/adtech, with fake doctors like "Dr. Tucker Carl Zinn, MD." (13:35)
- Evaluation: The story is less "AI/solo founder disrupts everything" and more about pushing boundaries in digital marketing.
2. Regulatory Deep Dive: GLP-1, Telehealth, and the FDA
Guest: Dr. Jonathan Slotkin (Geisinger/Scrub Capital)
[93:04–106:23]
- Key Takeaway: The MedV story omitted serious issues—recent FDA warning letters, lawsuits, and violation of medical practice standards.
- Slotkin: “I wanted this story to be true...but revenue, when it’s absent some of the needed regulatory context, that’s where we need to go deeper.” [93:44]
- On Safety and Efficacy: Some products marketed have “zero evidence base whatsoever.” The warning letter issue isn’t just procedural—it’s about patient safety.
- Structural Problem: Gap between FDA (controls substances) and states (regulate practice of medicine) creates a “regulatory daylight” for overhyped/unsafe telehealth plays.
- The Need for Clarity: Suggests that business model innovation must be paired with regulatory compliance and true value-add—otherwise “snake oil” erodes real progress.
3. The AI Boom: $200B Burn Rates, New Careers, Shifting Economy
[39:00–55:19 | Host discussion, Liz Hoffman guest segment at [107:24–120:33]]
- AI Training Cost Explosion:
- OpenAI and Anthropic are projected to spend (and lose) tens to hundreds of billions per year on model training by 2028.
- Debate over “YOLO” (OpenAI’s aggressive spending, pushing for early IPO) vs. “conservative” approaches (Anthropic).
- "Such losses would dwarf that of virtually any other public company in history." (39:00)
- Organizational Implications: Friction/tension between visionary CEOs and risk-conscious CFOs.
- SaaS, Electricity, or Railroads?: Ongoing uncertainty in how to model and value generative AI businesses.
- AI and Jobs:
- AI has birthed 640,000 new U.S. jobs (2023–25, LinkedIn).
- Real “head of AI” roles proliferating, even as AI is predicted to automate up to a quarter of current working hours.
- "This may be the first tech revolution to benefit blue-collar over white-collar work." — Liz Hoffman [110:43]
- Cautious optimism: most recent survey suggests little real negative employment effect from AI so far.
4. The Long Tail of App Development and Solo AI Products
[25:30–26:58]
- App Store Sees 85% Quarter-over-Quarter Growth: Much driven by solo/AI-assisted development, but no Flappy Bird/Balatro-level hits—yet.
- Quote: "I'm waiting for the Flappy Bird moment... the viral moment that breaks through." [26:02, John]
5. China’s Tech Playbook to 2030 and Beyond
[27:03–65:53]
- Industrial Overcapacity Example: Skyscrapers full of pigs—China now produces too much pork, driving economic and cultural shifts. [27:03–30:11]
- Drastic Shift in AI Talent: For the first time, more lead AI research authors are based in China than the U.S. (mitigated by the U.S. labs going closed-source).
- China’s Tech Master Plan:
- 2030/2035: Aims for dominance in AI, 6G, humanoid robots, quantum computing, fusion energy, and more.
- Strong state intervention—resembles “Elon Musk’s fever dream.”
- “Can China move from catch-up to dominance in frontier tech?”
- Skepticism remains: best Chinese models build on Western open-source, and chip/semiconductor dependencies linger.
- Regulatory Adversity: U.S. counter-reactions to “Made in China 2025” evidence heightened tech decoupling.
6. The U.S. Copycat Drone & Shift in Defense Innovation
[31:01–37:05]
- Narrative Violation: The U.S. now reverse-engineers and mass-produces the Iranian “Shahed”-type drone due to its low cost and effectiveness.
- Government Adaptability: For first time in 50 years, U.S. swiftly copies adversarial tech in an openly “good enough/affordable” way.
- “They’re calling it the Toyota Corolla of drones.”
- Raises questions about future battlefield tech, U.S. scaling speed, and the broader impact of war on government procurement.
7. Real-World Application Spotlights
a) Stablecoins Clearinghouse – Better Money (Sam Broner)
[75:54–92:47]
- $10M raised to create a clearinghouse for stablecoin transactions, making them as seamless to use as ACH for global treasury/payment use cases post-GENIUS Act.
- Quote: "The need [for CBDC] might have dried up...private stablecoins that are well regulated are working." [78:32]
b) Customer Experience AI Agents – Sierra (Bret Taylor)
[120:54–139:15]
- Sierra reached $100M ARR in 7 quarters, launching Ghostwriter (an agent for building agents), focusing on large enterprise transformation.
- "We think the era of the web app is kind of over...most people are just going to be talking to AI agents."
- The core enterprise sales lesson: “If a CEO avoids regular customer contact, their sales org will never be elite.” [139:15]
- Japan market entry via the acquisition of local "Sierra of Japan"—a model for cross-regional expansion.
c) Factory Superintelligence for Shipbuilding – GrayMatter Robotics (Ariyan Kabir)
[140:49–147:14]
- Partnership with Huntington Ingalls Industries to automate and scale U.S. shipbuilding amid a supercharged China.
- "90% of U.S. manufacturing is still manual—agents/robotics and AI are key to bridging the industrial capacity gap."
d) Workforce Financial Infrastructure – Branch (Atif Siddiqi)
[147:15–156:03]
- Branch drives instant payouts (e.g., Uber, Instacart), reducing worker churn—now integrating via Stripe’s Connect platform to serve gig/1099 workforces.
- End-to-end tax filing for contractors, and embedded finance for vertical SaaS.
- Daily instant pay becoming “table stakes.”
Notable Quotes & Memorable Moments
- On Overhyped Solo Startups:
- "We have two employees, but 800 fake doctors." — [19:03]
- “Isn't that interstellar for chuds?” — [00:31]
- On China’s Ambitions:
- "China wants to build skies dotted with flying taxis, fusion-fueled factories manned by humanoid robots..." [57:10]
- On U.S. Defense:
- “The Toyota Corolla of drones.” [31:27]
- On the Future of Work:
- “This may be the first tech revolution that benefits blue-collar over white-collar workers.” — Liz Hoffman [110:43]
- Enterprise Sales Litmus Test:
- "Does that CEO spend time with their own customers? If not, their B2B org will never be elite." — Bret Taylor [139:15]
- On Life/Career Wisdom (from thread):
- “Being tall doesn’t matter. Being lean does.” / “Everyone is lonely. Be the friend you wish you had.”* [71:30–74:13]
Timestamps for Key Segments
- GLP-1/MedV Deep Dive: 02:16–19:49
- Regulatory Analysis w/ Dr. Slotkin: 93:04–106:23
- AI Capital Arms Race & Jobs: 39:00–55:19 / 107:24–120:33
- China’s Tech Strategy: 27:03–65:53
- Defense Tech (Lucas Drone): 31:01–37:05
- Better Money/Stables: 75:54–92:47
- Sierra / AI Agents: 120:54–139:15
- GrayMatter Robotics: 140:49–147:14
- Branch / Workforce Finance: 147:15–156:03
Conclusion
This episode of TBPN masterfully weaves between macro themes (the globalization and weaponization of AI, regulatory arms races, China’s industrial ambitions) and "how it's actually being built" stories (telehealth startups, the real challenges in payroll/finance, the nuts and bolts of physical & digital automation). The recurring motif: scale and disruption are not always as they seem—true innovation requires as much rigor (especially legal/regulatory) as it does vision and code.
If you want to understand the promises and perils of the new "AI economy," the future of the U.S.-China rivalry, and what actually works in bringing radical tech to market, this episode is must-listen TBPN.
